{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:04Z","timestamp":1791726124763,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20221402"],"award-info":[{"award-number":["DFL20221402"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173862"],"award-info":[{"award-number":["82173862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpba.2025.117286","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:54:54Z","timestamp":1764230094000},"page":"117286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring the anti-tuberculosis activity mechanism of OTB-658: Multi-omics analysis"],"prefix":"10.1016","volume":"270","author":[{"given":"Qiyue","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117286_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jpba.2025.117286_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/microorganisms13040722","article-title":"Innovative strategies for combating multidrug-resistant tuberculosis: advances in drug delivery systems and treatment","volume":"13","author":"Omoteso","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.jpba.2025.117286_bib3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jpba.2025.117286_bib4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.apsb.2025.01.023","article-title":"Revolutionizing tuberculosis treatment: breakthroughs, challenges, and hope on the horizon","volume":"15","author":"Kufa","year":"2025","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.jpba.2025.117286_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117093","article-title":"Validation and clinical application of an LC-MS\/MS method designed to simultaneously measure seven second-line TB drugs and two metabolites in human lung tissue","volume":"266","author":"Foster","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117286_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.003","article-title":"World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward","volume":"55","author":"Van Deun","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2025.117286_bib7","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/molecules26144280","article-title":"Oxazolidinone antibiotics: chemical, biological and analytical aspects","volume":"26","author":"Foti","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2025.117286_bib8","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2147\/JMDH.S507827","article-title":"Risk assessment of Linezolid-associated neurological adverse drug reactions based on the food and drug administration adverse event reporting system database","volume":"18","author":"Yin","year":"2025","journal-title":"J. Multidiscip. Health"},{"key":"10.1016\/j.jpba.2025.117286_bib9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug. Des. Dev. Ther."},{"key":"10.1016\/j.jpba.2025.117286_bib10","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1021\/acs.jmedchem.0c00500","article-title":"Discovery of a conformationally constrained oxazolidinone with improved safety and efficacy profiles for the treatment of multidrug-resistant tuberculosis","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2025.117286_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00974-21","article-title":"In vitro and in vivo activity of oxazolidinone candidate OTB-658 against mycobacterium tuberculosis","volume":"65","author":"Guo","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117286_bib12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc-2022-0079","article-title":"Recent advances in oxazolidinones as antituberculosis agents","volume":"14","author":"Lu","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jpba.2025.117286_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01399-22","article-title":"Efficacy of replacing linezolid with OTB-658 in anti-tuberculosis regimens in Murine models","volume":"67","author":"Liu","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117286_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eng.2024.02.009","article-title":"An update on the clinical pipelines of new antibacterial drugs developed in China","volume":"38","author":"Yang","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.jpba.2025.117286_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116829","article-title":"Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility","volume":"279","author":"Zhong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2025.117286_bib16","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/AAC.00152-16","article-title":"Role of the Cys154Arg substitution in ribosomal protein L3 in oxazolidinone resistance in mycobacterium tuberculosis","volume":"60","author":"Makafe","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117286_bib17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.06227-11","article-title":"rplC T460C identified as a dominant mutation in linezolid-resistant mycobacterium tuberculosis strains","volume":"56","author":"Beckert","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117286_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00284-012-0104-9","article-title":"Genome-wide expression profiling of the response to linezolid in mycobacterium tuberculosis","volume":"64","author":"Liang","year":"2012","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.jpba.2025.117286_bib19","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.2174\/0929867323666151106125759","article-title":"Oxazolidinones as anti-tubercular agents: discovery, development and future perspectives","volume":"22","author":"Jadhavar","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2025.117286_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1096\/fba.2020-00022","article-title":"Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline","volume":"2","author":"Burke","year":"2020","journal-title":"FASEB Bioadv."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:57:49Z","timestamp":1773849469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525006272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"alternative-id":["S0731708525006272"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117286","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the anti-tuberculosis activity mechanism of OTB-658: Multi-omics analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117286"}}